Csaba A.
- Country
- Hungary
- Department
- "C" Pszichiátriai Osztály
Research Overview
- Efficacy and Safety of NBI-1065845 as Adjunctive Therapy in Adults with Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Study
- Evaluation of Long-Term Safety and Tolerability of NBI-1065845 as Adjunctive Therapy in Adults with Major Depressive Disorder
- Study of Trospium Chloride and Xanomeline Tartrate (KarXT) for Treating Mania in Adults with Bipolar I Disorder
Data & Insights
Has run more than one trial at 33 of 106 partner sites.
Specializations
Epilepsy and seizure disorders
Csaba Almasi is involved in clinical research on difficult-to-control epileptic conditions, with attention to refractory focal onset epilepsy, refractory status epilepticus, and prolonged seizure episodes.
- Refractory focal onset epilepsy
- Refractory status epilepticus
- Partial-onset seizures
- Staccato alprazolam
- Cenobamate
His therapeutic focus includes acute seizure control and longer-term management of seizure burden in both pediatric and adult populations.
Neuropsychiatry and mood disorders
His research landscape includes treatment development for major depressive disorder and bipolar-I disorder, particularly mania and mania with mixed features.
- Major depressive disorder
- Bipolar-I mania
- Mania with mixed features
- NBI-1065845
- KarXT
These activities reflect a therapeutic interest in symptom reduction and maintenance treatment options for severe psychiatric illness.
Movement disorders and neurodegeneration
Csaba Almasi is active in studies addressing progressive neurologic disease, with emphasis on Parkinson's disease and primary progressive multiple sclerosis.
- Parkinson's disease
- Primary progressive multiple sclerosis
- Tavapadon
- Ocrelizumab
This area includes therapeutic interest in symptom control and disability-related outcomes in chronic neurologic disease.
Headache and acute neurological care
His trial involvement also extends to migraine treatment and urgent neurological conditions such as acute ischemic stroke.
- Migraine
- Acute ischemic stroke
- Atogepant
- Redasemtide
These studies place him within therapeutic domains focused on rapid symptom relief and early intervention in cerebrovascular disease.
Cardiovascular, metabolic, and imaging research
His clinical research portfolio includes atrial fibrillation, hypertriglyceridemia, and contrast-enhanced magnetic resonance imaging in both adult and pediatric settings.
- Atrial fibrillation
- Hypertriglyceridemia
- Contrast-enhanced magnetic resonance imaging
- Gadoquatrane
- Milvexian
- Plozasiran
This involvement spans cardiovascular prevention, lipid-lowering therapy, and diagnostic imaging support for central nervous system evaluation.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.